|
Vazyme Biotech Co
chamq universal sybr qpcr mastermix kit ![]() Chamq Universal Sybr Qpcr Mastermix Kit, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/chamq universal sybr qpcr mastermix kit/product/Vazyme Biotech Co Average 99 stars, based on 1 article reviews
chamq universal sybr qpcr mastermix kit - by Bioz Stars,
2026-05
99/100 stars
|
Buy from Supplier |
|
New England Biolabs
luna universal probe qpcr master mix ![]() Luna Universal Probe Qpcr Master Mix, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/luna universal probe qpcr master mix/product/New England Biolabs Average 99 stars, based on 1 article reviews
luna universal probe qpcr master mix - by Bioz Stars,
2026-05
99/100 stars
|
Buy from Supplier |
|
Igene Biotechnology Inc
all in onetm mirna qpcr kit ![]() All In Onetm Mirna Qpcr Kit, supplied by Igene Biotechnology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/all in onetm mirna qpcr kit/product/Igene Biotechnology Inc Average 86 stars, based on 1 article reviews
all in onetm mirna qpcr kit - by Bioz Stars,
2026-05
86/100 stars
|
Buy from Supplier |
|
Yeasen Biotechnology
hifair ii 1st strand cdna synthesis supermix for qpcr ![]() Hifair Ii 1st Strand Cdna Synthesis Supermix For Qpcr, supplied by Yeasen Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/hifair ii 1st strand cdna synthesis supermix for qpcr/product/Yeasen Biotechnology Average 86 stars, based on 1 article reviews
hifair ii 1st strand cdna synthesis supermix for qpcr - by Bioz Stars,
2026-05
86/100 stars
|
Buy from Supplier |
|
Yeasen Biotechnology
hieff qpcr sybr green master mix ![]() Hieff Qpcr Sybr Green Master Mix, supplied by Yeasen Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/hieff qpcr sybr green master mix/product/Yeasen Biotechnology Average 86 stars, based on 1 article reviews
hieff qpcr sybr green master mix - by Bioz Stars,
2026-05
86/100 stars
|
Buy from Supplier |
|
Yeasen Biotechnology
hieff unicon qpcr sybr green master mix ![]() Hieff Unicon Qpcr Sybr Green Master Mix, supplied by Yeasen Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/hieff unicon qpcr sybr green master mix/product/Yeasen Biotechnology Average 86 stars, based on 1 article reviews
hieff unicon qpcr sybr green master mix - by Bioz Stars,
2026-05
86/100 stars
|
Buy from Supplier |
|
Vazyme Biotech Co
taq pro universal sybr qpcr master mix ![]() Taq Pro Universal Sybr Qpcr Master Mix, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/taq pro universal sybr qpcr master mix/product/Vazyme Biotech Co Average 99 stars, based on 1 article reviews
taq pro universal sybr qpcr master mix - by Bioz Stars,
2026-05
99/100 stars
|
Buy from Supplier |
|
Vazyme Biotech Co
chamq sybr qpcr master mix ![]() Chamq Sybr Qpcr Master Mix, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/chamq sybr qpcr master mix/product/Vazyme Biotech Co Average 96 stars, based on 1 article reviews
chamq sybr qpcr master mix - by Bioz Stars,
2026-05
96/100 stars
|
Buy from Supplier |
|
Vazyme Biotech Co
chamqtm universal sybr qpcr master mix ![]() Chamqtm Universal Sybr Qpcr Master Mix, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/chamqtm universal sybr qpcr master mix/product/Vazyme Biotech Co Average 99 stars, based on 1 article reviews
chamqtm universal sybr qpcr master mix - by Bioz Stars,
2026-05
99/100 stars
|
Buy from Supplier |
Journal: Synthetic and Systems Biotechnology
Article Title: XRE-type transcriptional regulator ProR controls prodigiosin synthesis in Serratia marcescens JNB5-1
doi: 10.1016/j.synbio.2026.02.014
Figure Lengend Snippet: ProR indirectly positively regulates the expression level of the prodigiosin-related pig gene cluster. (A) Growth curves of strains JNB5-1, SK6-61, SK6-61/pXW2010, SK6-61/pUCP18, Δ proR , Δ proR /pXW2010, and Δ proR /pUCP18. (B) Unit cell production of prodigiosin of strains JNB5-1, SK6-61, SK6-61/pXW2010, SK6-61/pUCP18, Δ proR , Δ proR /pXW2010, and Δ proR /pUCP18. (C) RT-qPCR analysis of the relative expression levels of the pigABCDEFGHIJKLMN genes in strains JNB5-1 and Δ proR . (D) β-galactosidase activity assay of strains SK68 and JNB5-1 carrying the P pigA - lacZ reporter gene. (E) Electrophoretic mobility shift assay (EMSA) demonstrating the binding capacity of ProR protein to the promoter region of the pig operon. Each reaction mixture contains 100 ng of PCR products. The protein concentrations are indicated above the lanes. (A to D) The experiment was performed independently three times. Error bars indicate standard deviations. Student's t-test was used to examine the mean differences between the data groups. ∗∗∗∗, P < 0.001.
Article Snippet: RT-qPCR analyses were performed on 200 ng/μL cDNA with
Techniques: Expressing, Quantitative RT-PCR, Activity Assay, Electrophoretic Mobility Shift Assay, Binding Assay
Journal: Journal of Sport and Health Science
Article Title: Long-term aerobic exercise enhances circulating exosomal miR-214-3p to promote endothelial progenitor cell-mediated repair of endothelial damage induced by obesity
doi: 10.1016/j.jshs.2025.101094
Figure Lengend Snippet: Circulating exosomal miR-214-3p regulated the function of EPC in both humans and rats with obesity. (A and B) Targeted transcriptome sequencing of miRNAs within circulating exosomes derived from (A) humans and (B) rats unveiled the regulatory impact of aerobic exercise on miRNA expression profiles in these vesicles. The left panel shows a volcano plot of differentially expressed genes, and the right panel shows a heatmap representation of the transcriptome sequencing data, illustrating the expression patterns of differentially expressed genes in circulating exosomes. (C and D) qPCR was used to validate the relative expression levels of miR-214-3p in circulating exosomes derived from (C) humans ( n = 3 for each group; * p < 0.05, Exercise vs . Control) and (D) rats ( n : 6–12 for each group; * p < 0.05, HC vs . NC; # p < 0.05, HE vs . HC). (E) qPCR validation of miR-214-3p expression in miR-214-3p-overexpressing EPC ( n = 3 for each group). ** p < 0.01, miR-214-3p mimics vs . mimics NC; ## p < 0.01, miR-214-3p mimics vs . Control. (F) Summary data for cell vitality level among groups ( n : 10–12 for each group). *** p < 0.001, miR-214-3p mimics vs . mimics NC. (G and H) Summary data (G) and representative images (H) of wound healing in the scratch assay, showcasing the migration level of EPC among groups ( n = 4 for each group). * p < 0.05, miR-214-3p mimics vs . mimics NC. EPC = endothelial progenitor cells; HC = the high-fat diet with sedentary group; HE = the high-fat diet with exercise group; mimics NC = mimics negative control; miR = microRNA; NC = the normal diet with sedentary group; qPCR = quantitative polymerase chain reaction.
Article Snippet: Total RNAs from tissues, cells, and exosomes were extracted using Trizol (R0016; Beyotime Biotech, Shanghai, China), following the manufacturer’s recommendations. mRNA samples underwent reverse transcription using the Evo M-MLV Kit (AG11705; Accurate Biotechnology, Changsha, China), while miRNA samples were reversely transcribed using the
Techniques: Sequencing, Derivative Assay, Expressing, Control, Biomarker Discovery, Wound Healing Assay, Migration, Negative Control, Real-time Polymerase Chain Reaction
Journal: Journal of Sport and Health Science
Article Title: Long-term aerobic exercise enhances circulating exosomal miR-214-3p to promote endothelial progenitor cell-mediated repair of endothelial damage induced by obesity
doi: 10.1016/j.jshs.2025.101094
Figure Lengend Snippet: miR-214-3p plays an essential role in exercise-mediated protection against obesity-induced EPC dysfunction in vivo . (A) Dynamic weight change curves of rats. After randomization at Week 10, rats underwent treadmill exercise until the end of Week 18 ( n : 5–7 for each group). * p < 0.05, KO + HE vs . WT + NC; ### p < 0.001, WT + HC vs . WT + NC; ††† p < 0.001, WT + HE vs . WT + NC; ‡‡‡ p < 0.001, WT + HE vs . WT + HC; §§ p < 0.01, KO + HE vs . WT + HE. (B) Summary data for Lee's index among groups at Week 10 and Week 18 ( n : 5–7 for each group). Left panel: ** p < 0.01, KO + HE vs . WT + NC; ### p < 0.001, WT + HC vs . WT + NC; ††† p < 0.001, WT + HE vs . WT + NC; Right panel: *** p < 0.001, KO + HE vs . WT + HC; ### p < 0.001, WT + HC vs . WT + NC; ‡‡‡ p < 0.001, WT + HE vs . WT + HC. (C) Summary data for acetylcholine (ACh)-induced, endothelium-dependent relaxation in mesenteric arteries among groups ( n : 5–6 for each group). * p < 0.05, WT + HE vs . KO + HE; # p < 0.05, ## p < 0.05, WT + HE vs . WT + HC. (D) Summary data for EC 50 values in mesenteric arteries among groups in response to ACh ( n : 5–6 for each group). * p < 0.05, KO + HE vs . WT + HE; ## p < 0.01, WT + HE vs . WT + HC; ‡‡ p < 0.01, WT + HC vs . WT + NC. (E) Cell proliferation assays demonstrated that exosomes derived from the WT + HC group exhibited a diminished capacity to promote EPC proliferation compared to the WT + NC group in rats. In contrast, exosomes derived from the WT + HE group significantly enhanced EPC proliferation, which was abolished by knocking out miR-214-3p in rats ( n = 10 for each group). *** p < 0.001, KO + HE vs . WT + HE; ### p < 0.001, WT + HE vs . WT + HC; ‡‡ p < 0.01, WT + HC vs . WT + NC. (F) Scratch assay results showed that exosomes derived from the WT + HC group exhibited a diminished capacity to enhance EPC migration rates compared to the WT + NC group in rats. In contrast, exosomes derived from the WT + HE group significantly enhanced EPC migration rates, which was abolished by knocking out miR-214-3p in rats ( n = 6 for each group). *** p < 0.001, KO + HE vs . WT + HE; ### p < 0.001, WT + HE vs . WT + HC; ‡‡ p < 0.01, WT + HC vs . WT + NC. (G) Representative images of wound healing in the scratch assay, showcasing the migratory response of rat EPC. (H) qPCR analyses of pre-miR-214-3p and miR-214-3p in tissues from obese rats with and without exercise training ( n : 4–6 for each group). *** p < 0.001, HE vs . HC. EC 50 = half maximal effective concentration; EPC = endothelial progenitor cells; HC = the high-fat diet with sedentary group; HE = the high-fat diet with exercise group; KO + HE = the knockout + high-fat diet with exercise group; miR = microRNA; pre-miR = precursor microRNA; WT + HC = the wild-type + high-fat diet with sedentary group; WT + HE = the wild-type + high-fat diet with exercise group; WT + NC = the wild-type + normal diet with sedentary group.
Article Snippet: Total RNAs from tissues, cells, and exosomes were extracted using Trizol (R0016; Beyotime Biotech, Shanghai, China), following the manufacturer’s recommendations. mRNA samples underwent reverse transcription using the Evo M-MLV Kit (AG11705; Accurate Biotechnology, Changsha, China), while miRNA samples were reversely transcribed using the
Techniques: In Vivo, Derivative Assay, Wound Healing Assay, Migration, Concentration Assay, Knock-Out
Journal: Bioactive Materials
Article Title: Mesenchymal stromal cells-loaded 3D radially aligned composite scaffold with potentiated paracrine signaling for sequential bone regeneration
doi: 10.1016/j.bioactmat.2026.02.059
Figure Lengend Snippet: Temporal analysis of the BMSC paracrine profile on different scaffolds. (A) Confocal microscopy images from Live/Dead fluorescence staining of BMSCs encapsulated within the PCL/HAp-GelMA/BMSCs scaffold after 1, 3, 5, and 14 d of 3D culture (live cells, green; dead cells, red). (B) The concentrations of key paracrine factors (TGF-β, PGE2, VEGF, HGF, and BMP-2) from BMSCs cultured in different scaffolds, quantified from culture supernatants at day 3 and day 7. (C) Corresponding relative mRNA expression levels of TGFB1, PTGS2, VEGFA, HGF, and BMP-2 in BMSCs at day 3 and day 7, as determined by qPCR analysis. Data are presented as mean ± SD (n = 3) *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001; ns: not significant.
Article Snippet: Subsequently, quantitative real-time PCR (RT-qPCR) was performed using
Techniques: Confocal Microscopy, Fluorescence, Staining, Cell Culture, Expressing
Journal: Non-coding RNA Research
Article Title: CircSMAD4 shapes matrix-remodeling TAMs in lung adenocarcinoma
doi: 10.1016/j.ncrna.2026.03.003
Figure Lengend Snippet: circSMAD4 is enriched in LUAD TAMs and is associated with advanced disease and poor prognosis. (A) Workflow for isolating human LUAD TAMs and paired normal tissue-resident macrophages (NTRMs) for circRNA profiling. (B) Heatmap of the top differentially expressed circRNAs between TAMs and NTRMs (z-score logCPM). (C) Volcano plot of circRNA-seq (TAMs vs NTRMs) showing differentially expressed circRNAs. Differential-expression categories were defined as follows: Up (red), log2FC ≥ 1 and FDR <0.05; Down (blue), log2FC ≤ −1 and FDR <0.05; all remaining circRNAs were classified as Normal (gray). (D) RT–qPCR validation of selected circRNA candidates in TAMs versus NTRMs. (E) Independent cohort validation showing higher circSMAD4 expression in TAMs than in NTRMs. (F) Representative images of combined CD68 immunofluorescence (green) and circSMAD4 ISH (red) in LUAD tumor and adjacent normal tissues; nuclei were counterstained with DAPI (blue). Scale bar, 50 μm. (G) Kaplan–Meier analysis of overall survival stratified by circSMAD4 expression in TAMs (high vs low). (H) Schematic of circSMAD4 genomic origin and back-splice junction validation by Sanger sequencing. (I) Divergent-primer PCR showing circSMAD4 detection in cDNA but not gDNA; GAPDH serves as a linear control. (J, L) RNase R digestion assay showing resistance of circSMAD4 relative to linear SMAD4 mRNA in patient-derived TAMs (J) and TC-BMDMs (L). (K, M) Actinomycin D chase assay showing greater stability of circSMAD4 than SMAD4 mRNA in patient-derived TAMs (K) and TC-BMDMs (M). Half-life estimated by one-phase decay (Y0 = 1, Plateau = 0). ∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001; ∗∗∗∗P < 0.0001; ns, not significant.
Article Snippet: Reverse transcription for mRNA/circRNA was performed with HiScript III (Vazyme, Cat# R312-01), and miRNA reverse transcription was performed using the Vazyme miRNA RT system. qPCR was carried out using
Techniques: Quantitative Proteomics, Quantitative RT-PCR, Biomarker Discovery, Expressing, Immunofluorescence, Sequencing, Control, Derivative Assay
Journal: Non-coding RNA Research
Article Title: CircSMAD4 shapes matrix-remodeling TAMs in lung adenocarcinoma
doi: 10.1016/j.ncrna.2026.03.003
Figure Lengend Snippet: circSMAD4 drives tumor-educated M2-like polarization of macrophages and promotes tumor-cell aggressiveness. (A) Workflow for generating TC-hMDMs and TC-BMDMs, circSMAD4 knockdown, and downstream functional assays. (B) RT–qPCR analysis of M1-associated markers (MHC-II [HLA-DRA in TC-hMDMs; H2-Ab1 in TC-BMDMs], NOS2, and CD86) and M2-associated markers (CD163, CD206, and ARG1) in TC-hMDMs and TC-BMDMs. (C) Representative flow-cytometry histograms for HLA-DR, iNOS, CD86, CD163, CD206, and ARG1 in TC-hMDMs. Gating strategy and marker thresholds were defined based on FMO controls (see ). (D) Flow-cytometry quantification of marker-positive cells in TC-hMDMs and TC-BMDMs. (E) ELISA of IL-10, TGF-β, and iNOS in culture supernatants. (F) CCK-8 assays of A549 and LLC cells. (G) Colony-formation assays of A549 and LLC cells with quantification. (H) Bioluminescence-based growth readouts of patient-derived LUAD organoids (PDO #1 and PDO #2) after co-culture with TC-hMDMs. (I) Immunoblot analysis of EMT-related proteins (E-cadherin, N-cadherin, Vimentin) in A549 and LLC cells. (J) Transwell migration and invasion assays of A549 and LLC cells with quantification. Scale bar, 50 μm. ∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001; ∗∗∗∗P < 0.0001; ns, not significant.
Article Snippet: Reverse transcription for mRNA/circRNA was performed with HiScript III (Vazyme, Cat# R312-01), and miRNA reverse transcription was performed using the Vazyme miRNA RT system. qPCR was carried out using
Techniques: Knockdown, Functional Assay, Quantitative RT-PCR, Flow Cytometry, Marker, Enzyme-linked Immunosorbent Assay, CCK-8 Assay, Derivative Assay, Co-Culture Assay, Western Blot, Migration
Journal: Non-coding RNA Research
Article Title: CircSMAD4 shapes matrix-remodeling TAMs in lung adenocarcinoma
doi: 10.1016/j.ncrna.2026.03.003
Figure Lengend Snippet: circSMAD4 physically associates with IGF2BP2 in macrophages. (A) LC–MS/MS summary of proteins enriched by circSMAD4 RNA pull-down. (B) Western blot validation of IGF2BP2 in circSMAD4 sense (vs antisense) pull-down from TC-hMDMs. (C) IGF2BP2 RIP–qPCR showing circSMAD4 enrichment over IgG in TC-hMDMs. (D–E) catRAPID prediction and ViennaRNA RNAfold secondary-structure modeling indicating multiple candidate IGF2BP2-binding regions on circSMAD4. (F) Western blot of IGF2BP2 after pull-down with circSMAD4 fragments (1#–3#). (G) Schematic of IGF2BP2 domain architecture and the Flag-tagged truncation/deletion constructs used for mapping circSMAD4 interaction (designed based on catRAPID prediction and annotated RRM/KH domain boundaries). (H) Anti-Flag RIP–qPCR showing circSMAD4 enrichment precipitated by the indicated Flag-tagged IGF2BP2 truncation/deletion constructs (presented as % input and normalized to IgG). (I) Nuclear–cytoplasmic fractionation followed by RT–qPCR showing circSMAD4 distribution and the effect of IGF2BP2 knockdown on the nuclear-to-cytoplasmic ratio of circSMAD4 in TC-hMDMs. Fractionation quality was validated using nuclear/cytoplasmic marker transcripts/proteins. (J) Representative immunofluorescence/ISH images showing circSMAD4 signals and IGF2BP2 staining in macrophages (CD163) with nuclear counterstaining (DAPI). Scale bar, 50 μm. (K–N) qPCR and Western blot showing no reciprocal change in expression between circSMAD4 and IGF2BP2 upon knockdown/overexpression. ∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001; ∗∗∗∗P < 0.0001; ns, not significant.
Article Snippet: Reverse transcription for mRNA/circRNA was performed with HiScript III (Vazyme, Cat# R312-01), and miRNA reverse transcription was performed using the Vazyme miRNA RT system. qPCR was carried out using
Techniques: Liquid Chromatography with Mass Spectroscopy, Western Blot, Biomarker Discovery, Binding Assay, Construct, Fractionation, Quantitative RT-PCR, Knockdown, Marker, Immunofluorescence, Staining, Expressing, Over Expression
Journal: Non-coding RNA Research
Article Title: CircSMAD4 shapes matrix-remodeling TAMs in lung adenocarcinoma
doi: 10.1016/j.ncrna.2026.03.003
Figure Lengend Snippet: circSMAD4 facilitates IGF2BP2-dependent stabilization of m6A-marked transcripts. (A) Venn diagram intersecting ENCORI-predicted IGF2BP2 targets with DEGs from shIGF2BP2 versus shNC and shcircSMAD4 versus shNC mRNA-seq, identifying shared candidates. (B) MeRIP–qPCR showing m6A enrichment on COL4A1, SPI1, and ACTA2 candidate regions (CRDs) in shNC and shIGF2BP2 cells. (C) IGF2BP2-RIP–qPCR showing IGF2BP2 binding to COL4A1, SPI1, and ACTA2 CRDs in shNC + Vector, shcircSMAD4 + Vector, shNC + IGF2BP2, and shcircSMAD4 + IGF2BP2 groups. (D) Biotin-circSMAD4 pull-down followed by qPCR showing enrichment of COL4A1, SPI1, and ACTA2 CRDs in Vector + shNC, circSMAD4 + shNC, Vector + shIGF2BP2, and circSMAD4 + shIGF2BP2 groups. (E–G) Schematics of m6A-site mutations introduced into COL4A1, SPI1, and ACTA2 reporters. (H–J) Dual-luciferase assays for CRD reporters (WT and m6A-mutant) in Vector, circSMAD4, and IGF2BP2 groups. (K–M) MeRIP–qPCR for WT and m6A-mutant CRD reporters in Vector, circSMAD4, and IGF2BP2 groups. (N–P) mRNA decay assays of endogenous COL4A1, SPI1, and ACTA2 following circSMAD4 knockdown with Vector or IGF2BP2 overexpression. Half-life estimated by one-phase decay (Y0 = 1, Plateau = 0). (Q–S) mRNA decay assays of endogenous COL4A1, SPI1, and ACTA2 following circSMAD4 overexpression with shNC or shIGF2BP2. Half-life estimated by one-phase decay (Y0 = 1, Plateau = 0). ∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001; ∗∗∗∗P < 0.0001; ns, not significant.
Article Snippet: Reverse transcription for mRNA/circRNA was performed with HiScript III (Vazyme, Cat# R312-01), and miRNA reverse transcription was performed using the Vazyme miRNA RT system. qPCR was carried out using
Techniques: Binding Assay, Plasmid Preparation, Luciferase, Mutagenesis, Knockdown, Over Expression